Keywords
type 1 diabetes, self management, patient education
To date, evaluations of the structured diabetes education programme, Dose Adjustment for Normal Eating (DAFNE), have focused on improvements in clinical and psychosocial outcomes, however, little is known about implementation and participant attendance across centres. We compared participant profile, course delivery and retention across Irish and UK centres and patterns of course delivery pre and during Covid-19.
Data collected annually by DAFNE centres (01.01.2019 to 01.01.2022) were analysed. Multivariable logistic regression assessed the association between demographic (age, gender) and clinical variables (years since diagnosis; DKA requiring admission in past 12 months; severe hypoglycaemic event (hypo) in the last year), course format and country, with non-completion (attended <5 sessions).
Overall, 6749 people attended DAFNE courses across 91 centres in 3 years. Compared to Ireland, UK-based course attendees were slightly older on average and had diabetes for longer. In 2019 (pre-Covid), 86 centres delivered an average of 10 courses per centre (range: 1 to 30). During Covid (2020) when remote format courses were first offered, 79 centres delivered an average of 5 courses per centre (1 to 15). Overall, 10% of participants did not complete. Younger age, having a severe hypo in the last year, and attending a remote course (vs. standard 5-day face-to-face) were associated with non-completion.
Course delivery varies widely across centres. This may reflect centre size and resource availability. Although participant non-completion was low, our data do not capture those who withdraw pre-course. Future work should explore barriers and facilitators of course acceptance and retention.
type 1 diabetes, self management, patient education
Diabetes management involves trying to achieve optimal glycaemia by maintaining in target HbA1c without frequent hypoglycemia1. Hyperglycaemia is associated with an increased risk of microvascular and macrovascular complications2. Self-management is therefore key, and increasing emphasis has been placed on structured education programmes which incorporate experiential learning and skill-based training3,4. Dose Adjustment for Normal Eating (DAFNE) is a structured education programme for people with type 1 diabetes, recommended by national guidelines in the UK5 and Ireland6. It has been shown to be effective at improving HbA1c level and quality of life, as well as reducing the frequency of hypoglycaemic events among participants of the programme7–9.
In the UK, DAFNE roll out occurred from 2002 onwards10 and is now delivered in 81 centres nationally. In Ireland, six centres established DAFNE as part of initial roll-out from 2004. However, the programme has been prioritised for national expansion relatively recently, following the release of national guidelines (2018)6 and enhanced resourcing from the Integrated Care Programme for Chronic Disease. There are currently 21 registered DAFNE centres in the Republic of Ireland11. To date, evaluations of DAFNE, both in the UK and Ireland, have demonstrated clinical effectiveness and improvements in psychosocial outcomes12. However, little is known about how the programme is implemented across sites and how best to support sustainment. Previous studies have identified challenges with the ongoing implementation of structured diabetes education programmes, including delivery of specific course components (e.g., goal setting)13, and non-attendance14–16.
DAFNE is the only structured education programme that is currently available in Ireland that meets all the criteria of the clinical recommendations regarding structured patient education for people with type 1 diabetes. It is important to learn from ongoing implementation to identify aspects that may need to be improved. This will inform the development of strategies to support widespread implementation. There is also scope to learn from comparing sites at different stages of implementation (Ireland vs. UK), and in light of recent changes to the format, namely, the rapid shift to remote delivery in response to Covid-19. Therefore, as part of a wider programme of research17 to develop tailored strategies to support delivery we conducted an analysis of an extract from the DAFNE Central dataset to compare participant profile, course delivery and retention among Irish and UK centres and patterns of course delivery pre and post Covid-19.
DAFNE is run by a multidisciplinary team of educators over approximately 40 hours and offered in a variety of formats, including face-to-face, blended and fully remote, launched in July 2020 in response to Covid-19. Typically, there are 6–8 participants per course (4-6 for remote courses) (Supplemental File 1).
All DAFNE centres in the UK and Ireland submit data on course delivery and participants on an annual basis to an anonymised central clinical database. We analysed an extract of pre and post course data (Supplemental File 2) for courses delivered between 01.01.2019 and 01.01.2022. Permission was sought from each Irish DAFNE centre who had submitted data during the extract period (n=10) to identify the centre within the dataset. At the time of the extract [Q1 2022], four Irish centres were new (delivered DAFNE <5 years), six were considered established (i.e., delivered DAFNE for 5+ years). The STROBE reporting guidelines for cross-sectional studies were used to guide the reporting of the results.
We compared participant profile, course delivery (formats, number), course retention (number of days/weeks completed) across Irish and UK centres. We also compared participant profile pre and post course, and course delivery (formats, number) pre-Covid-19 (2019), and during Covid-19 (2020 and 2021).
Descriptive statistics (mean (sd), median (range), frequencies, percentages) were generated to examine the demographic and clinical profile of people pre-DAFNE course (i.e., age (dob), gender, ethnicity, year diagnosed, height, weight, HbA1c, number of severe hypoglycaemia events (unable to treat themselves) and diabetic ketoacidosis episode (DKAs), and courses attended (any session attended). Gender was based on self-report. Age was calculated using birth year and the year of course attendance.
Descriptive statistics were generated to examine the number of courses delivered overall and across centres. As data were provided at the level of the patient, to determine unique courses within the dataset for each centre, course delivery date and course format were used: standard DAFNE, 5X1 [Face to Face (F2F)], remote DAFNE [fully remote], remote DAFNE [blended with F2F support], pump DAFNE [F2F], remote pump DAFNE [fully remote]). We relied on the assumption that more than one course of the same format would not be delivered by the same centre on the same date. For example, if a standard DAFNE course was delivered at Centre 1 on 08-09-21 we assumed that represented a single course. Course delivery (formats, numbers) was compared between UK and Ireland, and pre and post Covid-19.
Repeaters were those repeating a DAFNE course. Non-completers were classified as people who attended less than 5 days of a course. It was not possible to determine from the dataset whether an individual recorded as attending only 4 days/weeks had completed a one-to-one session to compensate for the missed session, and thus graduated (Supplemental File 1). Differences in the demographic and clinical profile of people who did and did not complete a course, and differences in the profile of participants at UK and Irish centres were examined using cross tabulations and Pearson’s chi-squared or independent t tests.
Multivariable logistic regression was used to assess the association between demographic (age, gender) and clinical variables which could indicate condition severity (years since diagnosis; DKA requiring admission in past 12 months; hypoglycaemic event (hypo) in the last year unable to treat themselves), course format and country with non-completion. All analyses were complete case with the assumption that data were missing at random.
N and % missingness for each variable are reported. All data were managed and analysed using Stata SE 17.
Overall, 6749 people attended courses across 91 centres (2019-2022). Participants had a mean (sd) age of 41.8 (14.9) years, half were female (50.9%, n= 3438) (Table 1). Pre-course, one third had experienced at least one DKA requiring admission since diagnosis (32.8%, n=2216). Focusing just on the 12 months pre-course, 7.5% (n = 503) had experienced a DKA. Twelve percent (n = 812) had experienced a severe hypo in the last year. The profile of attendees across UK and Irish courses was similar at baseline with the exception that attendees of UK courses were slightly older on average and had diabetes for longer. A greater proportion of ethnic minorities also attended courses in the UK (13% vs. 5%) (Table 1)
Overall (N = 6749) | UK (N = 6370) | Ireland (N = 379) | |
---|---|---|---|
Variable | N (%) | N (%) | N (%) |
Age, mean (sd)*** | 41.8 (14.9) | 42.0 (14.9) | 38.5 (14.4) |
Years since diagnosis*** | 16.6 (13.6) | 16.7 (13.7) | 14.2 (11.6) |
Female | 3438 (50.9) | 3240 (50.9) | 198 (52.2) |
Ethnic minority | |||
Yes** | 856 (12.7) | 837 (13.1) | 19 (5.0) |
No | 5519 (81.8) | 5171 (81.2) | 348 (91.8) |
Prefer not to say | 232 (3.4) | 226 (3.6) | 6 (1.6) |
Type of diabetes | |||
Type 1 | 6500 (96.3) | 6135 (96.3) | 365 (96.3) |
Otherα | 173 (2.6) | 167 (2.6) | 6 (1.6) |
Type 2 | 41 (23.7) | 39 (23.4) | 2 (33.3) |
Pancreatic | 50 (28.9) | 48 (28.0) | 2 (33.3) |
Secondary | 21 (12.1) | 21 (12.6) | 0 (0) |
Cystic Fibrosis | 9 (5.2) | 9 (5.4) | 0 (0) |
MODY | 6 (3.5) | 6 (3.6) | 0 (0) |
Other | 35 (20.2) | 34 (20.4) | 1 (16.7) |
Not reported | 11 (6.4) | 10 96.0) | 1 (16.7) |
Method of insulin delivery | |||
MDI | 6323 (93.7) | 5963 (93.6) | 360 (95.0) |
Pump | 359 (5.3) | 340 (5.3) | 19 (5.0) |
HbA1c (mmol/mol) [% NGSP], mean (sd) | 67 (17) [8.3 (1.6)] | 67 (18) [8.3(1.6)] | 66 (14) [8.2 (1.3)] |
BMI (kg/m2), mean (sd) | 27.2 (6.2) | 27.2 (6.3) | 26.6 (4.7) |
DKA requiring admission since dx | 2216 (32.8) | 2089 (32.8) | 127 (33.5) |
DKA requiring admission in 12 months before course** | 503 (7.5) | 488 (7.7) | 15 (4.0) |
Severe hypoglycaemic event in the last year | 812 (12.0) | 773 (12.2) | 39 (10.3) |
Blood glucose level when patient usually experiences symptoms of hypoglycaemia | |||
Does not feel symptoms | 224 (3.3) | 215 (3.4) | 9 (2.4) |
Greater than/equal to 3mmol/litre | 5106 (75.7) | 4805 (75.4) | 301 (79.4) |
Less than 3mmol/litre | 1289 (19.1) | 1223 (19.2) | 66 (17.4) |
*N (%) missingness: Diagnosis = 65 (1.0%); Gender = 40 (0.6%); Type 1 = 76 (1.1%); Ethnicity = 142 (2%); Days attended MDI format = 58 (2.2%); Days attended pump format = 6 (2.1%); Course format = 163 (2.4%); Method of insulin delivery = 67 (1%); HbA1c = 554 (8%); BMI = 700 (10%); DKA requiring admission since dx= 219 (3%); DKA requiring admission 12 months before course = 328 (5%); Hypo in last year unable to treat = 64 (1%); Of those with Hypos, N Hypo in last year unable to treat = 13 (2%); Of those with Hypos, N Hypo in last year requiring paramedic = 38 (5%); Of those with Hypos, N Hypo in last year requiring hospital admission = 42 (5%); Blood glucose symptoms = 130 (2%).
**Chi squared test to explore differences between UK and Irish centres P ≤0.001
***Independent t test P ≤0.001
αNote represent % within the ‘Other’ category
Pre and post course data could be linked for 3976 graduates, however there were high levels of missingness post course. Of those who had experienced a DKA requiring admission in the 12 months pre-course (n = 297), 4% (n = 12) experienced a DKA in the 12 months post-course. A higher proportion of course graduates reported having a severe hypoglycaemic event in the year before DAFNE compared to in the 12 months after completing DAFNE (12% vs. 4%). Patterns were similar for Irish and UK centres (Table 2).
*HbA1c: 6 (2.9%) missing pre-course, 9 (4.4%) missing post-course; Weight: 9 (4.4%) people missing pre-course, 59 (28.3%) missing post-course; DKA: 17 (8.3%) missing pre-course, 30 (14.6%) missing post-course; Hypos: 0 (0) missing pre-course, 22 (10.7%) missing post course.
**HbA1c: 218 (7.8%) missing pre-course, 335 (8.9%) missing post-course; Weight: 246 (6.5%) people missing pre-course, 1490 (39.5%) missing post-course; DKA: 200 (5.3%) missing pre-DAFNE, 1258 (33.4%) missing post-course; Hypos: 39 (1.0%) missing pre-course, 1139 (30.2%) missing post-course.
Course numbers. In total, 91 centres delivered 1257 courses between 01.01.2019 and 01.01.2022, a median of 17 courses, ranging from 2 to 74 across centres. Annual course numbers varied widely; taking 2019 (pre-Covid) as a reference for usual delivery, 86 centres delivered an average of 10 courses per centre (range: 1 to 30) courses annually. In contrast, during Covid (2020) 79 centres delivered an average of 5 courses (1 to 15). The proportion of centres delivering over 10 courses was substantially lower in 2020, but by 2021 the proportion was similar to pre-Covid levels (Figure 1).
Comparing the UK and Ireland, in 2019, 78 UK centres delivered 533 courses, an average of 10 per centre (range: 1 to 30). In contrast, in the same year, 8 Irish centres delivered an average of 4 courses per centre (1 to 6).
Course formats. Most people attended the standard DAFNE (5-day, face-to-face) (57.3%, n = 3864) or fully remote DAFNE (24.5%, n = 1652) (Table 3). In Ireland, a greater proportion of participants had attended fully remote DAFNE compared with the UK (34% vs. 24% of courses delivered). UK centres had a greater proportion of participants attending 5X1 day courses (14% vs. 8%).
Overall (N = 6749) | UK (N = 6370) | Ireland (N = 379) | |
---|---|---|---|
Variable | N (%) | N (%) | N (%) |
Course type | |||
Standard DAFNE | 3864 (57.3) | 3666 (57.6) | 198 (52.2) |
5x1 (F2F) | 923 (13.7) | 892 (14.0) | 31 (8.2) |
Remote DAFNE (fully remote) | 1652 (24.5) | 1524 (23.9) | 128 (33.8) |
Remote DAFNE (blended w/ F2F support) | 29 (0.4) | 25 (0.4) | 4 (1.1) |
Pump DAFNE (F2F) | 174 (2.6) | 162 (2.5) | 12 (3.2) |
Remote Pump DAFNE (fully remote) | 107 (1.6) | 101 (1.6) | 6 (1.6) |
Attending at least 1 day of MDI format course | 6234 (92.4) | 5876 (92.2) | 358 (94.5) |
Days attended MDI format‖ | |||
1 | 110 (1.7) | 104 (1.8) | 6 (1.7) |
2 | 67 (1.1) | 63 (1.1) | 4 (1.1) |
3 | 78 (1.2) | 73 (1.2) | 5 (1.4) |
4 | 343 (5.5) | 321 (5.5) | 22 (6.2) |
5 | 5636 (90.4) | 5315 (90.5) | 321 (89.7) |
Not completing MDI (<5 days) | 598 (9.6) | 561 (9.6) | 37 (10.3) |
Attending at least 1 day of pump course | 352 (5.2) | 333 (5.2) | 19 (5.0) |
Days attended pump format*‖ | |||
1 | 8 (2.3) | 8 (2.4) | 0 (0) |
2 | 2 (0.6) | 2 (0.6) | 0 (0) |
3 | 3 (0.9) | 3 (0.9) | 0 (0) |
4 | 35 (9.9) | 32 (9.6) | 3 (15.8) |
5 | 304 (86.4) | 288 (86.5) | 16 (84.2) |
Not completing pump (<5 days) | 48 (13.6) | 45 (13.5) | 3 (15.8) |
Repeater | 197 (2.9) | 179 (2.8) | 18 (4.8) |
Course year | |||
2019 | 3660 (54.2) | 3473 (54.5) | 187 (49.3) |
2020 | 1407 (20.9) | 1357 (21.3) | 50 (13.2) |
2021 | 1682 (24.9) | 1540 (24.2) | 142 (37.5) |
*N(%) missingness: Repeater = 93 (1.4%); Days attended MDI format = 58 (2.2%); Days attended pump format = 6 (2.1%); Course format = 163 (2.4%)
‖25 people who indicated ‘Yes’ to attending MDI courses, reported number of days attending pump courses; 1 person who indicated ‘yes’ to attending pump courses, reported number of days attending MDI courses
The number of people attending courses dropped substantially in 2020 and 2021, and the proportion of people attending standard DAFNE format dropped over the three years (77.6% (n =2 839/3660); 56.3% (n = 792/1407); 13.9% (n = 233/1682). Comparing 2020 and 2021 the proportion attending a fully remote DAFNE course increased from 31.3% (n=441/1047) to 78.4% (n = 1318/1682).
Overall, 10% (n = 646/6586) of participants did not complete. A higher proportion of non-completers were from remote MDI DAFNE (blended) and remote pump DAFNE than other course formats (Supplementary Table 1). There were a higher proportion of non-completers from pump courses (n = 48, 13.6%) than MDI courses (n = 598, 9.6%). Non-completion was similar in the UK (10%; 606/6370) in the UK, and Ireland (11%; 40/379). In the UK a greater proportion of people did not complete DAFNE 5x1 courses compared to Ireland (21% (n = 127) vs. 12.5% (n = 5))
People who did not complete were, on average, younger than those who did not complete (mean [sd] 39.0 (14.0) vs. 42.1 [14.9]). A higher proportion of those who did not complete had experienced a severe hypoglycaemic event in the past 12 months (16.7% vs. 11.7%). There were no significant differences between those who did and did not complete with respect to other variables (gender, DKA in the past 12 months, years since diagnosis). In the multivariable model, factors independently associated with non-completion were age, a severe hypoglycaemic event in the past 12 months, and course format (Table 4).
Variable | OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|
Age | 0.99 (0.98, 0.99)* | 0.99 (0.98, 0.99)* |
Gender (Female) | ||
Male | 0.98 (0.83, 1.15) | 1.09 (0.91, 1.30) |
Prefer not to say | 2.11 (0.60, 7.44) | 1.55 (0.33, 1.67) |
Years since diagnosis | 1.00 (0.99, 1.00) | 1.00 (0.99, 1.01) |
DKA in last 12 months requiring admission | 1.43 (1.08, 1.89) | 1.45 (1.08, 1.96) |
Hypo in the last year unable to treat themselves | 1.54 (1.23, 1.92)* | 1.64 (1.29, 1.09)* |
Course format (Standard DAFNE) | ||
5x1 (F2F) | 3.10 (2.46, 3.92)* | 3.24 (2.53, 4.16) |
Remote DAFNE (fully remote) | 3.44 (2.83, 4.18)* | 3.56 (2.90, 4.35) |
Remote DAFNE (blended w/ F2F support) | 6.81 (2.98, 15.57)* | 6.65 (2.77, 15.96)* |
Pump DAFNE (F2F) | 1.74 (1.01, 3.02) | 1.86 (1.03, 3.37) |
Remote Pump DAFNE (fully remote) | 6.03 (3.81, 9.55)* | 7.04 (4.36, 11.39)* |
Country (UK) | ||
Ireland | 1.10 (0.78, 1.54) | 0.95 (0.66, 1.38) |
Overall missingness was low, with the exception of five variables where missingness was ≥ 5%: HbA1c (n = 554, 8%), BMI (n = 700, 10%); DKA requiring admission 12 months before course (n = 328, 5%); hypoglycaemic event (hypo) in last year requiring paramedic (n=38, 5% of those with hypo); hypo in last year requiring hospital admission (n = 42, 5% of those with hypo).
We analysed data on DAFNE courses delivered between 2019 and 2022, during which a median of 17 courses, ranging from 2 to 74 courses across centres, were delivered. Key findings relating to participant profile, course delivery, and retention are discussed below. These have implications for the roll-out of DAFNE currently underway in Ireland18.
Course attendees in the UK and Ireland were similar with the exception that Irish graduates were marginally younger and had a shorter duration of diabetes. This may suggest early offering of courses in the disease course to people with type 1 or may be simply indicative of the profile of people attending diabetes services in Ireland. Encouragingly, there was some evidence that courses reach those at risk of complications; 7.5% of graduates had experienced one DKA in the 12 months pre-course. This proportion is higher than previous reports from the UK; Elliot et al.19 reported that pre-course, 4.7% experienced at least one DKA requiring admission to hospital. However, only 12% of graduates had experienced a severe hypoglycaemic event in the last year, lower than previous reports indicating 25% had suffered at least one severe hypo in the year preceding DAFNE20. Encouragingly, both the proportion who had experienced DKA and a severe hypoglycaemic event in preceding 12 months, had dropped from pre to post DAFNE.
The few graduates of ethnic minority in Ireland likely reflects the different population profile, but this may change over time; 12% of the Irish population in 2022 are non-Irish, representing an increase from previous years21. It may be pertinent to plan to tailor the course for different cohorts. However, data on those offered, but who do not take up, a DAFNE course, are not collected or submitted centrally, although centres are advised to keep these data locally. Without knowing the profile of people who do not accept, or are not offered, a course, it is difficult to fully understand the reach of the programme and how it can be enhanced. Even if reach can be improved, in Ireland there is also a challenge of course supply. In previous work, people with type 1 diabetes have highlighted difficulties accessing a course22 and in March 2021 there were 713 people on a waiting list for DAFNE23. Access is improving with 21 registered centres in Ireland11, double the number of centres submitting data by the start of 2022.
As expected, the number of courses delivered dropped during Covid-19 but encouragingly numbers were rising again in 2021. DAFNE centres are at minimum required to deliver two courses annually and all educators must deliver a minimum of one course every six months in order to maintain skills10. However, course delivery in both the UK and Ireland varied by centre which may reflect the different size of centres, the availability of administrative support, the number of DAFNE trained staff, along with space and equipment to conduct in-person or remote courses; qualitative work is underway to explore these barriers to delivery within Irish DAFNE centres18. The wider variation evident in the UK in particular, could reflect a greater mix of centres. A greater proportion are also likely to have been established for longer. The number of centres delivering courses, and submitting data to the database, dropped during Covid (2020) (86 to 79); course delivery may have paused in some centres transitioning to remote format.
Overall, 10% of attendees did not complete courses. There are limited data on retention rates among people with type 1 diabetes. Previous work tends to focus on uptake; for example, data from the National Diabetes Audit in the UK suggests that approximately 90% of people with type 1 or 2 diabetes invited to structured education do not attend24. Studies of diabetes self-management education programmes for other cohorts have reported varying retention rates; 6% to 46% for community self-management programmes for type 2 diabetes25, 29% among the UK Diabetes Prevention Programme (DPP)26. However, these figures are not necessarily comparable given the different target population, course length (e.g., up to 14 sessions in the DPP) and format and focus on specific training in diabetes and insulin self-management skills. The referral process for courses for people with pre-diabetes, type 1 or 2 also differ, including when and how education is communicated to eligible patients and how much opportunity there is to discuss the course.
Interestingly a higher proportion of those who did not complete had experienced a severe hypoglycaemic event in the past 12 months (16.7% vs. 11.7%). While this could suggest challenges with disease management that may hinder people from continuing to attend the course, continuing attendance could be affected by a variety of factors, including work/life commitments and other personal challenges. Few studies have explored barriers to DAFNE attendance specifically. Harris et al.14 conducted a qualitative study in the UK among people who did not attend DAFNE, citing a variety of reasons broadly characterised as lack of psychological capability (diabetes distress, or lack of engagement in diabetes-associated activities), and lack of numerical capability to manage insulin dose adjustment. Irish DAFNE graduates participating in a photovoice study similarly cited the stress and time-consuming nature of detailed carbohydrate counting as a challenge22 albeit it did not deter them from completing the course.
Our findings suggest the proportion of people not completing pump courses was higher than MDI courses and that remotely delivered courses had a higher proportion of people not completing than in-person courses. It may be more difficult to arrange time off over a 5-week period as compared to 1 week (standard 5-day DAFNE). Work commitments have previously been cited as a barrier to attendance at diabetes education15 and the average age of DAFNE graduates was 42 years. With a remote model there may be less group support and cohesion which may discourage people from continuing with the programme. For example, attendees of the UK Digital DPP felt peer support and group interactions were lacking27.
This is the first analysis of data collected centrally on DAFNE which compared course delivery across the UK and Ireland and pre and during Covid-19, and which specifically examined predictors of course completion. There are some limitations. First, this analysis utilises data collected during a very specific time period, which includes the onset of the Covid-19 pandemic. While 2019 could represent pre-Covid-19 delivery, ideally a greater time window before the pandemic would be analysed. Second, we did not have information on the centres themselves bar knowledge of when Irish centres were established. Additional information on the centres and resources available, for example diabetes patient population size, staffing levels and space, along with experience delivering DAFNE, may help to understand and explore some of the variation in course numbers and formats. Third, courses were not attributed unique IDs in the dataset and so individual courses were identified by using course dates and formats; course numbers reported may be an underestimate. Finally, it is important to note that the people were considered to not complete if they did not complete all 5 days/weeks of the course, a strict definition. Of note, most people dropped out only on day/week four of their course, suggesting people who dropped out were engaged throughout most of the course. Further research is needed to understand the reasons for non-completion in later stages, for example whether this is due to other commitments or an expectation that the final session will not provide new material. A distinction should also be made between people who drop out early and later from courses.
In summary, course participant profiles in UK and Ireland were similar with the exception that Irish graduates were marginally younger and had diabetes for less time. We found wide variation in course delivery across UK centre in particular. Overall, approximately 10% of attendees did not complete courses. A higher proportion of people not completing remotely delivered courses than in-person courses, and those who did not complete were marginally younger on average than those who completed a course. Some of these key findings are being further explored through ongoing qualitative research which focuses on understanding challenges to delivering DAFNE in Ireland.
Data access is subject to ethical approval being granted for the study in question and a data release agreement being put in place.
This study involved a secondary analysis of anonymised data from the DAFNE Central database. Consent was not obtained from patients as part of this study.
The underlying data are not publicly available for this study. All DAFNE centres in the UK and Ireland submit data on course delivery and participants on an annual basis to this anonymised central clinical database. These data are stored and managed by the DAFNE Central Coordinating Centre, Northumbria Healthcare NHS Foundation Trust. Parties can apply to DAFNE Central to access a data extract. Data access is subject to ethical approval being granted for the study in question and a data release agreement being put in place.
This project contains the following extended data:
Overview of the DAFNE programme (Supplemental File 1) 10.5281/zenodo.11634636.
Data items requested from the extract (Supplemental File 2) 10.5281/zenodo.11634743.
Completion rates (MDI or pump) by course type (Supplementary Table 1) 10.5281/zenodo.11634766
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0)28.
Zenodo: STROBE checklist
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
No
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Clinical research; Systematic reviews; Randomized Clinical Trials; Collaborative research; Observational studies.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |
---|---|
1 | |
Version 1 23 Jul 24 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with HRB Open Research
Already registered? Sign in
Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research.
We'll keep you updated on any major new updates to HRB Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)